The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,012.00
Bid: 12,008.00
Ask: 12,012.00
Change: -16.00 (-0.13%)
Spread: 4.00 (0.033%)
Open: 12,052.00
High: 12,094.00
Low: 11,956.00
Prev. Close: 12,028.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 5-Trainee Indian doctors pulled from exams to fight world's biggest COVID surge

Mon, 03rd May 2021 05:41

* New cases rise by over 300,000 for 12th consecutive day

* Ratio of positive cases to tests drops for 1st time since
Apr 15

* Peak in cases may come May 3 to 5, modelling shows

* Epidemiologist calls for stay at home order, medical
emergency
(Writes through)

By Adnan Abidi and Shilpa Jamkhandikar

NEW DELHI/MUMBAI, May 3 (Reuters) - India postponed exams
for trainee doctors and nurses on Monday, freeing them up to
fight the world's biggest surge in coronavirus infections, as
the health system crumbles under the weight of new cases and
hospitals run out of beds and oxygen.

The total number of infections so far rose to just short of
20 million, propelled by a 12th straight day of more than
300,000 new cases in a pandemic sparked by a virus first
identified in central China at the end of 2019.

Medical experts say actual numbers in India could be five to
10 times higher than those reported.

Hospitals have filled to capacity, supplies of medical
oxygen have run short, and morgues and crematoriums have been
overloaded with corpses. Patients are dying on hospital beds, in
ambulances and in carparks outside.

"Every time we have to struggle to get our quota of our
oxygen cylinders," said B.H. Narayan Rao, a district official in
the southern town of Chamarajanagar, where 24 COVID-19 patients
died, some from a suspected shortage of oxygen supplies.

"It's a day-to-day fight," added Rao, as he described the
hectic scramble for supplies.

In many cases, volunteer groups have come to the rescue.

Outside a temple in the capital, New Delhi, Sikh volunteers
were providing oxygen to patients lying on benches inside
makeshift tents, hooked up to a giant cylinder. Every 20 minutes
or so, a new patient came in.

"No one should die because of a lack of oxygen. It's a small
thing otherwise, but nowadays, it is the one thing every one
needs," Gurpreet Singh Rummy, who runs the service, told
Reuters.

Total infections since the start of the pandemic have
reached 19.93 million in India, swelled by 368,147 new cases
over the past 24 hours, while the death toll rose by 3,417 to
218,959, health ministry data showed. At least 3.4 million
people are currently being treated.

Offering a glimmer of hope, the health ministry said
positive cases relative to the number of tests fell on Monday
for the first time since at least April 15.

Modelling by a team of government advisers shows coronavirus
cases could peak by Wednesday this week, a few days earlier than
a previous estimate, since the virus has spread faster than
expected.

At least 11 states and regions have ordered curbs on
movement to stem infections, but Prime Minister Narendra Modi's
government, widely criticised for allowing the crisis to spin
out of control, is reluctant to announce a national lockdown,
concerned about the economic impact.

"In my opinion, only a national stay at home order and
declaring medical emergency will help to address the current
healthcare needs," Bhramar Mukherjee, an epidemiologist with the
University of Michigan, said on Twitter.

CRISIS TESTS MODI

As medical facilities near breaking point, the government
postponed an exam for doctors and nurses to allow some to join
the coronavirus battle alongside existing personnel, it said in
a statement.
In Pune, the second-largest city in the state of Maharashtra,
Dr. Mekund Penurkar returned to work just days after losing his
father to COVID-19. His mother and brother are in hospital with
the virus, but patients are waiting to see him.

"It is a very difficult situation," he said. "Because I have
been through such a situation myself, I can't leave other
patients to their fate."

Modi has been criticised for not moving sooner to limit the
spread and for letting millions of largely unmasked people
attend religious festivals and crowded political rallies in five
states during March and April.

In early March, a forum of government scientific advisers
warned officials of a new and more contagious variant of the
coronavirus taking hold, five of its members told Reuters.

Despite the warning, four of the scientists said the federal
government did not seek to impose major curbs.

With the next general election due in 2024, it remains to be
seen how the pandemic might affect him or his party. His Hindu
nationalist party was defeated on Sunday in a state poll in the
eastern state of West Bengal, although it won in the
neighbouring state of Assam.

Leaders of 13 opposition parties urged Modi in a letter on
Sunday to immediately launch free national vaccinations and to
prioritise oxygen supplies to hospitals and health centres.

Despite being the world's biggest producer of vaccines,
India does not have enough for itself. Just 9% of a population
of 1.35 billion has received a dose.

Daily shots have fallen sharply from an all-time high
reached early last month as domestic companies struggle to boost
supplies. Vaccination centres in Mumbai were
deserted after the state government said it did not have enough
supplies to administer second doses for adults above 45.

Only limited doses were available for those aged 18-44 and
no walk-ins were allowed.

India has struggled to increase capacity beyond 80 million
doses a month due to a lack of raw materials and a fire at the
Serum Institute, which makes the AstraZeneca vaccine.

Another manufacturer, Pfizer Inc, is in talks with
the government for "expedited approval" of its vaccine, Chief
Executive Albert Bourla said on LinkedIn, announcing a donation
of medicines worth more than $70 million.

Last month, India said its drugs regulator would hand down a
decision within three days on emergency-use applications for
foreign vaccines, including that of Pfizer.

International aid has poured in in response to the crisis.

Britain will send another 1,000 ventilators to India, the
government said on Sunday. Prime ministers Boris Johnson and
Modi are set to talk on Tuesday.

The Indian COVID-19 variant has now reached at least 17
countries including Britain, Iran and Switzerland, spurring
several nations to close their borders to travellers from India.

(Reporting by Tanvi Mehta and Anuron Kumar Mitra; Additional
reporting by Sachin Ravikumar in Bengaluru; Writing by Michael
Perry and Nick Macfie; Editing by Lincoln Feast, Clarence
Fernandez, Raju Gopalakrishnan and Hugh Lawson)

More News
Today 08:54

IN BRIEF: AstraZeneca drug lowers cholesterol in phase 1 trial

AstraZeneca PLC - Cambridge, England-based pharmaceuticals - Reports positive results in a phase 1 trial of cholesterol drug candidate AZD0780, an oral small molecule PCSK9 inhibitor. Administered on top of rosuvastatin treatment, AZD0780 showed a statistically significant reduction in low-density lipoprotein cholesterol in plasma for test participants with hypercholesterolaemia, Astra says, while no serious adverse events were reported. "Elevated LDL-C levels in plasma is a key risk factor for cardiovascular disease and is estimated to cause 2.6 million deaths worldwide annually," Astra notes.

Read more
28 May 2024 07:02

AstraZeneca experimental lung cancer drug shows promising results

(Sharecast News) - AstraZeneca's experimental lung cancer drug showed improved overall survival rates in phase III trials, the pharmaceutical giant said on Tuesday.

Read more
27 May 2024 07:49

IN BRIEF: Astra, Daiichi hail positive survival data for Dato-DXd

AstraZeneca PLC - Cambridge, UK-based pharmaceutical firm - Alongside Japan's Daiichi Sankyo Co Ltd, notes positive data for datopotamab deruxtecan in phase III trial on lung cancer. Says the treatment, also known as Dato-DXd, showed a clinically meaningfully improvement in overall survival versus chemotherapy in advanced nonsquamous non-small cell lung cancer. The results build upon the positive progression-free survival findings presented back in 2023, Astra adds.

Read more
22 May 2024 09:53

LONDON BROKER RATINGS: Barclays cuts NextEnergy but lifts JLEN

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday:

Read more
22 May 2024 02:00

British firms expecting hard time in China market, lobby group warns

BEIJING, May 22 (Reuters) - British firms expect doing business in China to become harder over the next five years, a British business lobby group said on Wednesday, as Beijing strives to halt a retreat in foreign funds from a market once seen as the engine of global growth.

Read more
21 May 2024 19:00

Sector movers: Stocks slip amid light profit-taking

(Sharecast News) - Stocks ended a tad lower as investors waited on a raft of US central bank speakers scheduled for after the close of markets in London.

Read more
21 May 2024 17:20

Europe's STOXX 600 ends lower as rate uncertainty prevails

Focus on Fed minutes, Nvidia earnings

*

Read more
21 May 2024 17:04

LONDON MARKET CLOSE: London dips as eyes turn to UK inflation reading

(Alliance News) - Stock prices in London closed in the red on Tuesday, as investors nervously eye a key UK inflation reading, which could prompt the Bank of England to consider interest rate cuts.

Read more
21 May 2024 15:00

London close: Stocks fall ahead of key inflation reading

(Sharecast News) - London stocks ended in negative territory on Tuesday, influenced by the latest UK economic outlook from the International Monetary Fund (IMF) and comments from US Federal Reserve officials.

Read more
21 May 2024 12:03

CORRECT: Stocks fall but pound up as IMF ups UK forecast

(Correcting London Stock Exchange index prices.)

Read more
21 May 2024 12:00

LONDON MARKET MIDDAY: Stocks fall but pound up as IMF ups UK forecast

(Alliance News) - Stock prices in Europe were lower heading into Tuesday afternoon, with shares in New York also set for a muted open, as a recent rally for equities takes a pause.

Read more
21 May 2024 11:23

AstraZeneca aims for $80 bln in total revenue by 2030

Sees $80 bln in 2030 revenue by 2030

*

Read more
21 May 2024 09:04

LONDON MARKET OPEN: FTSE 100 declines after Asian stocks fall

(Alliance News) - Stock prices in London opened in the red on Tuesday, with some US interest rate cut optimism cooling after hawkish words from Federal Reserve central bankers.

Read more
21 May 2024 08:18

TOP NEWS: AstraZeneca eyes new era of growth with bold new revenue aim

(Alliance News) - AstraZeneca PLC on Tuesday set out its ambition to achieve USD80 billion in annual revenue by the end of the decade as it signalled a new "era of growth."

Read more
21 May 2024 07:52

LONDON BRIEFING: AstraZeneca plots "new era of growth"; SSP confident

(Alliance News) - London's FTSE 100 is called to open lower on Tuesday, following a mixed close in New York overnight, and tepid trade in Asia.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.